miR-122 promotes diabetic retinopathy through targeting TIMP3

References

• Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell. 136(2):215–233. doi: 10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Bourne RR, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Parodi MB, Pesudovs K, Price H, White RA, et al. 2014. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010. Br J Ophthalmol. 98(5):629–638. doi: 10.1136/bjophthalmol-2013-304033
   PubMed Web of Science ®Google Scholar
• Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. 2009. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 28(40):3526–3536. doi: 10.1038/onc.2009.211
   PubMed Web of Science ®Google Scholar
• Felekkis K, Touvana E, Stefanou C, Deltas C. 2010. microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia. 14(4):236.
   PubMed Web of Science ®Google Scholar
• Fu X, Ou B. 2020. Mir-152/LIN28B axis modulates high-glucose-induced angiogenesis in human retinal endothelial cells via VEGF signaling. J Cell Biochem. 121(2):954–962. doi: 10.1002/jcb.28978
   PubMed Web of Science ®Google Scholar
• Guo D, Ma J, Li T, Yan L. 2018. Up-regulation of miR-122 protects against neuronal cell death in ischemic stroke through the heat shock protein 70-dependent NF-κB pathway by targeting FOXO3. Exp Cell Res. 369(1):34–42. doi: 10.1016/j.yexcr.2018.04.027
   PubMed Web of Science ®Google Scholar
• Hewing NJ, Weskamp G, Vermaat J, Farage E, Glomski K, Swendeman S, Chan RVP, Chiang MF, Khokha R, Anand-Apte B, et al. 2013. Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Invest Ophthalmol Visual Sci. 54(1):864–870. doi: 10.1167/iovs.12-10954
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu Q, Zhang M, Yan Y, Yu H, Ge L. 2019. MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2. J Integr Neurosci. 18(1):57–64.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Zhu X, Liu X, Liu J. 2016. Effect of MiR-200b on retinal endothelial cell function in high-glucose condition and the mechanism. Nan Fang Yi Ke Da Xue Xue Bao. 36(4):577–581.
   PubMedGoogle Scholar
• Martinez B, Peplow PV. 2019. MicroRNAs as biomarkers of diabetic retinopathy and disease progression. Neural Regen Res. 14(11):1858. doi: 10.4103/1673-5374.259602
   PubMed Web of Science ®Google Scholar
• Pastukh N, Meerson A, Kalish D, Jabaly H, Blum A. 2019. Serum miR-122 levels correlate with diabetic retinopathy. Clin Exp Med. 19(2):255–260. doi: 10.1007/s10238-019-00546-x
   PubMed Web of Science ®Google Scholar
• Poulaki V, Mitsiades N, Iliaki E, Mitsiades C, Gragoudas E, Miller J. 2007. TIMP3 inhibits vascular leakage and leukostasis in an animal model of streptozotocin-induced diabetes. Invest Ophthalmol Visual Sci. 48(13):1383–1383.
   Google Scholar
• Qi JH, Anand-Apte B. 2015. Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism. Apoptosis. 20(4):523–534. doi: 10.1007/s10495-014-1076-y
   PubMed Web of Science ®Google Scholar
• Rao M, Zhu Y, Zhou Y, Cong X, Feng L. 2017. MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1. Am J Cancer Res. 7(2):323.
   PubMed Web of Science ®Google Scholar
• Rosewell KL, Li F, Puttabyatappa M, Akin JW, Brännström M, Curry TE Jr. 2013. Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle. Biol Reprod. 89(5):121–127. doi: 10.1095/biolreprod.112.106989
   PubMed Web of Science ®Google Scholar
• Schmidt AM. 2018. Highlighting diabetes mellitus: The epidemic continues. Arterioscler, Thromb, Vasc Biol. 38(1):e1–e8. doi: 10.1161/ATVBAHA.117.310221
   PubMed Web of Science ®Google Scholar
• Shafabakhsh R, Aghadavod E, Mobini M, Heidari-Soureshjani R, Asemi Z. 2019. Association between microRNAs expression and signaling pathways of inflammatory markers in diabetic retinopathy. J Cell Physiol. 234(6):7781–7787. doi: 10.1002/jcp.27685
   PubMed Web of Science ®Google Scholar
• Stewart MW. 2016. Treatment of diabetic retinopathy: recent advances and unresolved challenges. World J Diabetes. 7(16):333. doi: 10.4239/wjd.v7.i16.333
   PubMed Web of Science ®Google Scholar
• Thounaojam MC, Jadeja RN, Warren M, Powell FL, Raju R, Gutsaeva D, Khurana S, Martin PM, Bartoli M. 2019. MicroRNA-34a (miR-34a) mediates retinal endothelial cell premature senescence through mitochondrial dysfunction and loss of antioxidant activities. Antioxidants. 8(9):328. doi: 10.3390/antiox8090328
   Web of Science ®Google Scholar
• Wang L, Li H. 2020. miR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3. Biosci Rep. 40(4):BSR20193653. doi: 10.1042/BSR20193653
   PubMedGoogle Scholar
• Wang C, Lin Y, Fu Y, Zhang D, Xin Y. 2020. miR-221-3p regulates the microvascular dysfunction in diabetic retinopathy by targeting TIMP3. Pflug Arch Eur J Phy. 1–12.
   PubMed Web of Science ®Google Scholar
• Wang B, Wang H, Yang Z. 2012. miR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PloS One. 7(10):e47053. doi: 10.1371/journal.pone.0047053
   PubMed Web of Science ®Google Scholar
• Wang C-f, Yuan J-r, Qin D, Gu J-f, Zhao B-j, Zhang L, Zhao D, Chen J, Hou X-f, et al. 2016. Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats. J Ethnopharmacol. 185:162–170. doi: 10.1016/j.jep.2016.03.026
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang J, Chen X, Yang Y, Wang F, Li W, Awuti M, Sun Y, Lian C, et al. 2018. miR-365 promotes diabetic retinopathy through inhibiting Timp3 and increasing oxidative stress. Exp Eye Res. 168:89–99. doi: 10.1016/j.exer.2017.11.006
   PubMed Web of Science ®Google Scholar
• Wu J-h, Wang Y-h, Wang W, Shen W, Sang Y-z, Liu L, Chen C-m. 2016. miR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways. Int J Biochem Cell Biol. 73:41–52. doi: 10.1016/j.biocel.2016.02.002
   PubMed Web of Science ®Google Scholar
• Wu D-M, Wen X, Han X-R, Wang S, Wang Y-J, Shen M, Fan S-H, Zhuang J, Zhang Z-F, Shan Q, et al. 2018. miR-142-3p enhances cell viability and inhibits apoptosis by targeting CDKN1B and TIMP3 following sciatic nerve injury. Cell Physiol Biochem. 46(6):2347–2357. doi: 10.1159/000489626
   PubMedGoogle Scholar
• Xiao H, Liu Z. 2019. Effects of microRNA-217 on high glucose-induced inflammation and apoptosis of human retinal pigment epithelial cells (ARPE-19) and its underlying mechanism. Mol Med Rep. 20(6):5125–5133.
   PubMed Web of Science ®Google Scholar
• Zhao J, Gao S, Zhu Y, Shen X. 2018. Significant role of microRNA-219-5p in diabetic retinopathy and its mechanism of action. Mol Med Rep. 18(1):385–390.
   PubMed Web of Science ®Google Scholar